siRNA, Anti-IFT172, 2'-F/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT72208WQ-2F)
The product SIRGT72208WQ-2F is a type of small interfering RNA (siRNA) that targets IFT172 gene and regulates the expression of gene. The siRNA interferes with the expression of IFT172 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_015662.2 |
| Alternative Names | BBS20; NPHP17; RP71; SLB; SRTD10; osm-1; wim |
| Related Diseases | Short-Rib Thoracic Dysplasia 10 With Or Without Polydactyly |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT73208WQ-2MOE | IFT172 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT74208WQ-LNA | IFT172 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT71208WQ-RB | IFT172 | Human | Ribo-modified | ||
| SIRGT72208WQ-BB | IFT172 | Human | Backbone-modified |
